![5Z7 5Z7](https://data.pdbj.org/pdbjplus/data/cc/svg/5Z7.svg) | 5Z7 | Name: | 6-[4-(4-bromo-3-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione | Formula: | C15 H14 Br Cl N4 O3 | SMILES: | O=C(C1=CC(=O)NC(=O)N1)N1CCN(CC1)c1ccc(Br)c(Cl)c1 | InChi: | InChI=1S/C15H14BrClN4O3/c16-10-2-1-9(7-11(10)17)20-3-5-21(6-4-20)14(23)12-8-13(22)19-15(24)18-12/h1-2,7-8H,3-6H2,(H2,18,19,22,24) | Definition date: | 2021-07-28 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 6-[4-(4-bromo-3-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione |
|
![5ZJ 5ZJ](https://data.pdbj.org/pdbjplus/data/cc/svg/5ZJ.svg) | 5ZJ | Name: | 6-{4-[3-chloro-4-(trifluoromethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(1H,3H)-dione | Formula: | C16 H14 Cl F3 N4 O3 | SMILES: | O=C(C1=CC(=O)NC(=O)N1)N1CCN(CC1)c1ccc(c(Cl)c1)C(F)(F)F | InChi: | InChI=1S/C16H14ClF3N4O3/c17-11-7-9(1-2-10(11)16(18,19)20)23-3-5-24(6-4-23)14(26)12-8-13(25)22-15(27)21-12/h1-2,7-8H,3-6H2,(H2,21,22,25,27) | Definition date: | 2021-07-29 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 6-{4-[3-chloro-4-(trifluoromethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(1H,3H)-dione |
|
![5ZN 5ZN](https://data.pdbj.org/pdbjplus/data/cc/svg/5ZN.svg) | 5ZN | Name: | 2-chloro-4-[4-(2,6-dioxo-1,2,5,6-tetrahydropyrimidine-4-carbonyl)piperazin-1-yl]benzaldehyde | Formula: | C16 H15 Cl N4 O4 | SMILES: | O=C(C=1CC(=O)NC(=O)N=1)N1CCN(CC1)c1ccc(C=O)c(Cl)c1 | InChi: | InChI=1S/C16H15ClN4O4/c17-12-7-11(2-1-10(12)9-22)20-3-5-21(6-4-20)15(24)13-8-14(23)19-16(25)18-13/h1-2,7,9H,3-6,8H2,(H,19,23,25) | Definition date: | 2021-07-29 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-chloro-4-[4-(2,6-dioxo-1,2,5,6-tetrahydropyrimidine-4-carbonyl)piperazin-1-yl]benzaldehyde |
|
![5ZT 5ZT](https://data.pdbj.org/pdbjplus/data/cc/svg/5ZT.svg) | 5ZT | Name: | 6-{4-[3-chloro-4-(hydroxymethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(3H,5H)-dione | Formula: | C16 H17 Cl N4 O4 | SMILES: | O=C(C=1CC(=O)NC(=O)N=1)N1CCN(CC1)c1ccc(CO)c(Cl)c1 | InChi: | InChI=1S/C16H17ClN4O4/c17-12-7-11(2-1-10(12)9-22)20-3-5-21(6-4-20)15(24)13-8-14(23)19-16(25)18-13/h1-2,7,22H,3-6,8-9H2,(H,19,23,25) | Definition date: | 2021-07-30 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 6-{4-[3-chloro-4-(hydroxymethyl)phenyl]piperazine-1-carbonyl}pyrimidine-2,4(3H,5H)-dione |
|
![5ZW 5ZW](https://data.pdbj.org/pdbjplus/data/cc/svg/5ZW.svg) | 5ZW | Name: | 6-[4-(4-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione | Formula: | C15 H15 Cl N4 O3 | SMILES: | O=C(C1=CC(=O)NC(=O)N1)N1CCN(CC1)c1ccc(Cl)cc1 | InChi: | InChI=1S/C15H15ClN4O3/c16-10-1-3-11(4-2-10)19-5-7-20(8-6-19)14(22)12-9-13(21)18-15(23)17-12/h1-4,9H,5-8H2,(H2,17,18,21,23) | Definition date: | 2021-07-30 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 6-[4-(4-chlorophenyl)piperazine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione |
|
![H3F H3F](https://data.pdbj.org/pdbjplus/data/cc/svg/H3F.svg) | H3F | Name: | Tafenoquine | Formula: | C24 H28 F3 N3 O3 | SMILES: | COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(N[CH](C)CCCN)c2n1 | InChi: | InChI=1S/C24H28F3N3O3/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3/t15-/m0/s1 | Synonyms: | (4S)-N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine | Definition date: | 2020-10-30 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (4~{S})-~{N}4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine |
|
![H3L H3L](https://data.pdbj.org/pdbjplus/data/cc/svg/H3L.svg) | H3L | Name: | (1S)-1-(2-methyl-1,2,4-triazol-3-yl)ethanamine | Formula: | C5 H10 N4 | SMILES: | C[CH](N)c1ncnn1C | InChi: | InChI=1S/C5H10N4/c1-4(6)5-7-3-8-9(5)2/h3-4H,6H2,1-2H3/t4-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (1~{S})-1-(2-methyl-1,2,4-triazol-3-yl)ethanamine |
|
![H5R H5R](https://data.pdbj.org/pdbjplus/data/cc/svg/H5R.svg) | H5R | Name: | 2,7-dimethoxy-9-(piperidin-4-ylmethylsulfanyl)acridine | Formula: | C21 H24 N2 O2 S | SMILES: | COc1ccc2nc3ccc(OC)cc3c(SCC4CCNCC4)c2c1 | InChi: | InChI=1S/C21H24N2O2S/c1-24-15-3-5-19-17(11-15)21(26-13-14-7-9-22-10-8-14)18-12-16(25-2)4-6-20(18)23-19/h3-6,11-12,14,22H,7-10,13H2,1-2H3 | Definition date: | 2020-11-16 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2,7-dimethoxy-9-(piperidin-4-ylmethylsulfanyl)acridine |
|
![H69 H69](https://data.pdbj.org/pdbjplus/data/cc/svg/H69.svg) | H69 | Name: | 6-[4-(3,4-dichlorophenyl)piperidine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione | Formula: | C16 H15 Cl2 N3 O3 | SMILES: | O=C(C1=CC(=O)NC(=O)N1)N1CCC(CC1)c1ccc(Cl)c(Cl)c1 | InChi: | InChI=1S/C16H15Cl2N3O3/c17-11-2-1-10(7-12(11)18)9-3-5-21(6-4-9)15(23)13-8-14(22)20-16(24)19-13/h1-2,7-9H,3-6H2,(H2,19,20,22,24) | Definition date: | 2021-07-30 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 6-[4-(3,4-dichlorophenyl)piperidine-1-carbonyl]pyrimidine-2,4(1H,3H)-dione |
|
![RQW RQW](https://data.pdbj.org/pdbjplus/data/cc/svg/RQW.svg) | RQW | Name: | (1~{S},5~{S},6~{R})-10-(1,3-benzothiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylmethyl)-3,10-diazabicyclo[4.3.1]decan-2-one | Formula: | C23 H26 N4 O4 S2 | SMILES: | COC[CH]1CN(Cc2ccccn2)C(=O)[CH]3CCC[CH]1N3[S](=O)(=O)c4ccc5ncsc5c4 | InChi: | InChI=1S/C23H26N4O4S2/c1-31-14-16-12-26(13-17-5-2-3-10-24-17)23(28)21-7-4-6-20(16)27(21)33(29,30)18-8-9-19-22(11-18)32-15-25-19/h2-3,5,8-11,15-16,20-21H,4,6-7,12-14H2,1H3/t16-,20-,21+/m1/s1 | Synonyms: | (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylmethyl)-3,10-diazabicyclo[4.3.1]decan-2-one | Definition date: | 2020-10-20 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (1~{S},5~{S},6~{R})-10-(1,3-benzothiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylmethyl)-3,10-diazabicyclo[4.3.1]decan-2-one |
|
![RRZ RRZ](https://data.pdbj.org/pdbjplus/data/cc/svg/RRZ.svg) | RRZ | Name: | 2-[(1~{S},5~{S},6~{R})-10-[3,5-bis(chloranyl)phenyl]sulfonyl-5-ethenyl-2-oxidanylidene-3,10-diazabicyclo[4.3.1]decan-3-yl]ethanoic acid | Formula: | C18 H20 Cl2 N2 O5 S | SMILES: | OC(=O)CN1C[CH](C=C)[CH]2CCC[CH](N2[S](=O)(=O)c3cc(Cl)cc(Cl)c3)C1=O | InChi: | InChI=1S/C18H20Cl2N2O5S/c1-2-11-9-21(10-17(23)24)18(25)16-5-3-4-15(11)22(16)28(26,27)14-7-12(19)6-13(20)8-14/h2,6-8,11,15-16H,1,3-5,9-10H2,(H,23,24)/t11-,15+,16-/m0/s1 | Synonyms: | ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-vinyl-3,10-diazabicyclo[4.3.1]decan-3-yl)acetic acid | Definition date: | 2020-10-20 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-[(1~{S},5~{S},6~{R})-10-[3,5-bis(chloranyl)phenyl]sulfonyl-5-ethenyl-2-oxidanylidene-3,10-diazabicyclo[4.3.1]decan-3-yl]ethanoic acid |
|
![RSB RSB](https://data.pdbj.org/pdbjplus/data/cc/svg/RSB.svg) | RSB | Name: | (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylethyl)-3,10-diazabicyclo[4.3.1]decan-2-one | Formula: | C24 H28 N4 O4 S2 | SMILES: | COC[CH]1CN([CH](C)c2ccccn2)C(=O)[CH]3CCC[CH]1N3[S](=O)(=O)c4ccc5ncsc5c4 | InChi: | InChI=1S/C24H28N4O4S2/c1-16(19-6-3-4-11-25-19)27-13-17(14-32-2)21-7-5-8-22(24(27)29)28(21)34(30,31)18-9-10-20-23(12-18)33-15-26-20/h3-4,6,9-12,15-17,21-22H,5,7-8,13-14H2,1-2H3/t16-,17+,21+,22-/m0/s1 | Synonyms: | (1~{S},5~{S},6~{R})-10-(1,3-benzothiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-[(1~{S})-1-pyridin-2-ylethyl]-3,10-diazabicyclo[4.3.1]decan-2-one | Definition date: | 2020-10-20 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (1~{S},5~{S},6~{R})-10-(1,3-benzothiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-[(1~{S})-1-pyridin-2-ylethyl]-3,10-diazabicyclo[4.3.1]decan-2-one |
|
![4W8 4W8](https://data.pdbj.org/pdbjplus/data/cc/svg/4W8.svg) | 4W8 | Name: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-(4-methoxy-1H-indole-2-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C32 H35 N5 O5 S | SMILES: | COc1cccc2[NH]c(cc12)C(=O)N1CC2C(C1C(=O)NC(CC1CCNC1=O)C(O)c1nc3ccccc3s1)C2(C)C | InChi: | InChI=1S/C32H35N5O5S/c1-32(2)18-15-37(31(41)22-14-17-19(34-22)8-6-9-23(17)42-3)26(25(18)32)29(40)35-21(13-16-11-12-33-28(16)39)27(38)30-36-20-7-4-5-10-24(20)43-30/h4-10,14,16,18,21,25-27,34,38H,11-13,15H2,1-3H3,(H,33,39)(H,35,40)/t16-,18-,21-,25-,26-,27-/m0/s1 | Definition date: | 2021-07-15 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-(4-methoxy-1H-indole-2-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
![4YG 4YG](https://data.pdbj.org/pdbjplus/data/cc/svg/4YG.svg) | 4YG | Name: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(methanesulfonyl)-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C28 H39 N5 O6 S2 | SMILES: | CC(C)C(NS(C)(=O)=O)C(=O)N1CC2C(C1C(=O)NC(CC1CCNC1=O)C(O)c1nc3ccccc3s1)C2(C)C | InChi: | InChI=1S/C28H39N5O6S2/c1-14(2)21(32-41(5,38)39)27(37)33-13-16-20(28(16,3)4)22(33)25(36)30-18(12-15-10-11-29-24(15)35)23(34)26-31-17-8-6-7-9-19(17)40-26/h6-9,14-16,18,20-23,32,34H,10-13H2,1-5H3,(H,29,35)(H,30,36)/t15-,16-,18-,20-,21-,22-,23-/m0/s1 | Definition date: | 2021-07-15 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(methanesulfonyl)-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
![V8P V8P](https://data.pdbj.org/pdbjplus/data/cc/svg/V8P.svg) | V8P | Name: | (3R)-N-[(2S,3R)-1-(alpha-D-galactopyranosyloxy)-3-hydroxyheptadecan-2-yl]-3-hydroxyheptadecanamide | Formula: | C40 H79 N O9 | SMILES: | C(CCCCCCCCCCCCC(C(COC1C(C(O)C(C(O1)CO)O)O)NC(=O)CC(CCCCCCCCCCCCCC)O)O)C | InChi: | InChI=1S/C40H79NO9/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-32(43)29-36(45)41-33(31-49-40-39(48)38(47)37(46)35(30-42)50-40)34(44)28-26-24-22-20-18-16-14-12-10-8-6-4-2/h32-35,37-40,42-44,46-48H,3-31H2,1-2H3,(H,41,45)/t32-,33+,34-,35-,37+,38+,39-,40+/m1/s1 | Definition date: | 2020-07-17 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (3R)-N-[(2S,3R)-1-(alpha-D-galactopyranosyloxy)-3-hydroxyheptadecan-2-yl]-3-hydroxyheptadecanamide |
|
![P62 P62](https://data.pdbj.org/pdbjplus/data/cc/svg/P62.svg) | P62 | Name: | 5-[(4-chlorophenyl)methyl]-6-[[2-(dimethylamino)ethylamino]methyl]-4-oxidanyl-1~{H}-pyrimidine-2-thione | Formula: | C16 H21 Cl N4 O S | SMILES: | CN(C)CCNCC1=C(Cc2ccc(Cl)cc2)C(=NC(=S)N1)O | InChi: | InChI=1S/C16H21ClN4OS/c1-21(2)8-7-18-10-14-13(15(22)20-16(23)19-14)9-11-3-5-12(17)6-4-11/h3-6,18H,7-10H2,1-2H3,(H2,19,20,22,23) | Definition date: | 2020-12-02 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 5-[(4-chlorophenyl)methyl]-6-[[2-(dimethylamino)ethylamino]methyl]-4-oxidanyl-1~{H}-pyrimidine-2-thione |
|
![WCM WCM](https://data.pdbj.org/pdbjplus/data/cc/svg/WCM.svg) | WCM | Name: | (2S)-2-amino-3-(biphenyl-4-yl)-N-methyl-N-[(2S)-1-oxopropan-2-yl]propanamide (non-preferred name) | Formula: | C19 H22 N2 O3 | SMILES: | C(C(Cc2ccc(c1ccccc1)cc2)N)(N(C(C)C(O)=O)C)=O | InChi: | InChI=1S/C19H22N2O3/c1-13(19(23)24)21(2)18(22)17(20)12-14-8-10-16(11-9-14)15-6-4-3-5-7-15/h3-11,13,17H,12,20H2,1-2H3,(H,23,24)/t13-,17-/m0/s1 | Definition date: | 2020-10-13 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | (2S)-2-{[(2S)-2-amino-3-(biphenyl-4-yl)propanoyl](methyl)amino}propanoic acid (non-preferred name) |
|
![WTD WTD](https://data.pdbj.org/pdbjplus/data/cc/svg/WTD.svg) | WTD | Name: | 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide | Formula: | C20 H17 F2 N3 O5 | SMILES: | COc3cc(CCNC(C2=C(C(=O)N=C(c1c(cccc1F)F)N2)O)=O)ccc3O | InChi: | InChI=1S/C20H17F2N3O5/c1-30-14-9-10(5-6-13(14)26)7-8-23-19(28)16-17(27)20(29)25-18(24-16)15-11(21)3-2-4-12(15)22/h2-6,9,26-27H,7-8H2,1H3,(H,23,28)(H,24,25,29) | Definition date: | 2020-11-10 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide |
|
![WTG WTG](https://data.pdbj.org/pdbjplus/data/cc/svg/WTG.svg) | WTG | Name: | 2-(2-fluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide | Formula: | C20 H18 F N3 O5 | SMILES: | c3c(c(OC)cc(CCNC(=O)C2=C(O)C(=O)N=C(c1c(cccc1)F)N2)c3)O | InChi: | InChI=1S/C20H18FN3O5/c1-29-15-10-11(6-7-14(15)25)8-9-22-19(27)16-17(26)20(28)24-18(23-16)12-4-2-3-5-13(12)21/h2-7,10,25-26H,8-9H2,1H3,(H,22,27)(H,23,24,28) | Definition date: | 2020-11-10 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-(2-fluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide |
|
![WTM WTM](https://data.pdbj.org/pdbjplus/data/cc/svg/WTM.svg) | WTM | Name: | 2-(2-fluorophenyl)-5-hydroxy-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide | Formula: | C19 H17 F N4 O4 | SMILES: | C=1(NC(=O)C(=C(N=1)C(=O)NCCc2cc(OC)ncc2)O)c3ccccc3F | InChi: | InChI=1S/C19H17FN4O4/c1-28-14-10-11(6-8-21-14)7-9-22-18(26)15-16(25)19(27)24-17(23-15)12-4-2-3-5-13(12)20/h2-6,8,10,25H,7,9H2,1H3,(H,22,26)(H,23,24,27) | Definition date: | 2020-11-10 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-(2-fluorophenyl)-5-hydroxy-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
|
![YCV YCV](https://data.pdbj.org/pdbjplus/data/cc/svg/YCV.svg) | YCV | Name: | 2-[4-(1~{H}-indazol-4-yl)-2-methanoyl-6-methoxy-phenoxy]-~{N},~{N}-dimethyl-ethanamide | Formula: | C19 H19 N3 O4 | SMILES: | COc1cc(cc(C=O)c1OCC(=O)N(C)C)c2cccc3[nH]ncc23 | InChi: | InChI=1S/C19H19N3O4/c1-22(2)18(24)11-26-19-13(10-23)7-12(8-17(19)25-3)14-5-4-6-16-15(14)9-20-21-16/h4-10H,11H2,1-3H3,(H,20,21) | Definition date: | 2021-02-22 | Last modified: | 2021-11-05 | Release date: | 2021-11-10 | Identifier: | 2-[4-(1~{H}-indazol-4-yl)-2-methanoyl-6-methoxy-phenoxy]-~{N},~{N}-dimethyl-ethanamide |
|
![UED UED](https://data.pdbj.org/pdbjplus/data/cc/svg/UED.svg) | UED | Name: | N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C21 H31 N3 O5 | SMILES: | C(OC(=O)NC(C(NC(CO)CC1C(NCC1)=O)=O)CC(C)C)c2ccccc2 | InChi: | InChI=1S/C21H31N3O5/c1-14(2)10-18(24-21(28)29-13-15-6-4-3-5-7-15)20(27)23-17(12-25)11-16-8-9-22-19(16)26/h3-7,14,16-18,25H,8-13H2,1-2H3,(H,22,26)(H,23,27)(H,24,28)/t16-,17-,18-/m0/s1 | Synonyms: | GC373 bound form, GC376 bound form | Definition date: | 2020-05-11 | Last modified: | 2021-11-02 | Release date: | 2020-05-20 | Identifier: | N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
![ZRP ZRP](https://data.pdbj.org/pdbjplus/data/cc/svg/ZRP.svg) | ZRP | Name: | 4-anilino-6-(hexylamino)-N-methylquinoline-3-carboxamide | Formula: | C23 H28 N4 O | SMILES: | CNC(=O)c1cnc2ccc(cc2c1Nc1ccccc1)NCCCCCC | InChi: | InChI=1S/C23H28N4O/c1-3-4-5-9-14-25-18-12-13-21-19(15-18)22(20(16-26-21)23(28)24-2)27-17-10-7-6-8-11-17/h6-8,10-13,15-16,25H,3-5,9,14H2,1-2H3,(H,24,28)(H,26,27) | Definition date: | 2021-05-25 | Last modified: | 2021-10-29 | Release date: | 2021-11-03 | Identifier: | 4-anilino-6-(hexylamino)-N-methylquinoline-3-carboxamide |
|
![ZRV ZRV](https://data.pdbj.org/pdbjplus/data/cc/svg/ZRV.svg) | ZRV | Name: | 4-anilino-6-[4-(butylcarbamoyl)-3-fluorophenyl]-N-cyclopropyl-7-fluoroquinoline-3-carboxamide | Formula: | C30 H28 F2 N4 O2 | SMILES: | CCCCNC(=O)c1ccc(cc1F)c1cc2c(Nc3ccccc3)c(cnc2cc1F)C(=O)NC1CC1 | InChi: | InChI=1S/C30H28F2N4O2/c1-2-3-13-33-29(37)21-12-9-18(14-25(21)31)22-15-23-27(16-26(22)32)34-17-24(30(38)36-20-10-11-20)28(23)35-19-7-5-4-6-8-19/h4-9,12,14-17,20H,2-3,10-11,13H2,1H3,(H,33,37)(H,34,35)(H,36,38) | Definition date: | 2021-05-27 | Last modified: | 2021-10-29 | Release date: | 2021-11-03 | Identifier: | 4-anilino-6-[4-(butylcarbamoyl)-3-fluorophenyl]-N-cyclopropyl-7-fluoroquinoline-3-carboxamide |
|
![1I8 1I8](https://data.pdbj.org/pdbjplus/data/cc/svg/1I8.svg) | 1I8 | Name: | (3R)-N-[(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxidanylidene-propan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | Formula: | C33 H41 Cl N6 O2 | SMILES: | Clc1ccc(C[CH](NC(=O)[CH]2Cc3ccccc3CN2)C(=O)N4CCC(CC4)(Cn5cncn5)C6CCCCC6)cc1 | InChi: | InChI=1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1 | Definition date: | 2021-06-23 | Last modified: | 2021-10-29 | Release date: | 2021-11-03 | Identifier: | (3~{R})-~{N}-[(2~{R})-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxidanylidene-propan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
|